Proteasomes: Their role in cellular processes

Tsitologiya

Volumn 52, Issue 4, 2010, Pages 277-300

  Tsimokha, A S ^a  

^a INSTITUTE OF CYTOLOGY   (Russian Federation)

Author keywords

Apoptosis; Cell cycle; Differentiation; DNA repair; Immune response; Proteasomes; Transcription

Indexed keywords

ATP DEPENDENT 26S PROTEASE; PROTEASOME; PROTEIN; UBIQUITIN;

ANIMAL; ARTICLE; CELL CYCLE; CHEMISTRY; DNA REPAIR; HUMAN; METABOLISM; PHYSIOLOGY;

ANIMALS; CELL CYCLE; DNA REPAIR; HUMANS; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEINS; UBIQUITIN;

EID: 77952054343     PISSN: 00413771     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (310)

1. Adams J. 2001. Proteasome inhibition in cancer: development of PS-341. Semin. Oncol. 28 : 613-619.
2. Adams J. 2003. Potential for proteasome inhibition in the treatment of cancer. Drug Discov. Today. 8 : 307-315. (Pubitemid 36332222)
3. Adams J., Palombella V. J., Sausville E. A., Johnson J., Destree A., Lazarus D. D., Maas J., Pien C. S., Prakash S., Elliott P. J. 1999. Proteasome inhibitors: a novel class of potent and effective antitumor agents. Cancer Res. 59 : 2615-2622. (Pubitemid 29269108)
4. Adrain C., Creagh E. M., Cullen S. P., Martin S. J. 2004. Caspase-dependent inactivation of proteasome function during programmed cell death in Drosophila and man. J. Biol. Chem. 279 : 36 923 - 36 930.
5. Akhayat O., Infante A., Infante D., Martins S. A. C., de Grossi S. A. M. F., de Scherrer K. 1987. A new tipe of prosome-like particle, composed of small cytoplasmatic RNA and multimers of 21-kDa protein, inhibits protein synthesis in vitro. Eur. J. Biochem. 170 : 23-33. (Pubitemid 18028436)
6. Almond J. B., Snowden R. T., Hunter A., Dinsdale D., Cain K., Cohen G. M. 2001. Proteasome inhibitor-induced apoptosis of B-chronic lymphocytic leukaemia cells involves cytochrome c release and caspase activation, accompanied by formation of an approximately 700 kDa Apaf-1 containing apoptosome complex. Leukemia. 15 : 1388-1397. (Pubitemid 32785308)
7. Alvarez-Castelao B., Castaño J. G. 2005. Mechanism of direct degradation of IkappaBalpha by 20S proteasome. FEBS Lett. 579 : 4797-4802. (Pubitemid 41218666)
8. Amati B., Alevizopoulos K., Vlach J. 1998. Myc and the cell cycle. Front Biosci. 3 : 250-268.
9. Amerik A. Y., Hochstrasser M. 2004. Mechanism and function of deubiquitinating enzymes. Biochim. Biophys. Acta. 1695 : 189-207. (Pubitemid 39574973)
10. An B., Goldfarb R. H., Siman R., Dou Q. P. 1998. Novel dipeptidyl proteasome inhibitors overcome Bcl-2 protective function and selectively accumulate the cyclin-dependent kinase inhibitor p27 and induce apoptosis in transformed, but not normal, human fibro-blasts. Cell Death Differ. 5: 1062-1075. (Pubitemid 29008220)
11. Ang X. L., Wade Harper J. 2005. SCF-mediated protein degradation and cell cycle control. Oncogene. 24 (17) :2860-2870. (Pubitemid 40638095)
12. Arendt C. S., Hochstrasser M. 1999. Eukaryotic 20S proteasome catalytic subunit propeptides prevent active site inactivation by N-terminal acetylation and promote particle assembly. EMBO J. 18 : 3575-3585. (Pubitemid 29308838)
13. Arrigo A. P., Tanaka K., Goldberg A. L., Welch W. J. 1988. Identity of the 19S «prosome» particle with the large multifunctional protease complex of mammalian cells (the proteasome). Nature. 331 : 192-194. (Pubitemid 18042153)
14. Asher G., Lotem J., Sachs L., Kahana C., Shaul Y. 2002. Mdm-2 and ubiquitin-independent p53 proteasomal degradation regulated by NQO1. Proc. Nat. Acad. Sci. USA. 99: 13 125 - 13 130.
15. Auld K. L., Brown C. R., Casolari J. M., Komili S., Silver P. A. 2006. Genomic association of the proteasome demonstrates overlapping gene regulatory activity with transcription factor substrates. Mol. Cell. 21 : 861-871. (Pubitemid 43376135)
16. Auld K. L., Silver P. A. 2006. Transcriptional regulation by the proteasome as a mechanism for cellular protein homeostasis. Cell Cycle. 5 : 1503-1505. (Pubitemid 44091968)
17. Bach I., Ostendorf H. P. 2003. Orchestrating nuclear functions: ubiquitin sets the rhythm. TiBS. 28 : 189-195. (Pubitemid 36507157)
18. Ballut L., Petit F., Mouzeeyar S., Le Gall O., Candresse T., Schmid P., Nicolas P., Badaoui S. 2003. Biochemical identification of proteasome-associated endonuclease activity in sunflower. Biochim. biophys. acta. 1645 : 30-39. (Pubitemid 38234712)
19. Bardag-Gorce F., Venkatesh R., Li J., French B. A., French S. W. 2004. Hyperphosphorylation of rat liver proteasome subunits: the effects of ethanol and okadaic acid are compared. Life Sci. 75 : 585-597. (Pubitemid 38670265)
20. Baumeister W., Walz J., Zuhl F., Seemuller E. 1998. The proteasome: paradigm of a selfcompartmentalizing protease. Cell. 92 : 367-380.
21. Benaroudj N., Tarcsa E., Cascio P., Goldberg A. L. 2001. The unfolding of substrates and ubiquitin-independent protein degradation by proteasomes. Biochimie. 83 : 311-318. (Pubitemid 32293651)
22. Beyette J., Mason G., Murray R., Cohen G., Rivett J. 1998. Proteasome activities decrease during dexamethasone-induced apoptosis of thymocytes. Biochem. J. 332 : 315-320. (Pubitemid 28271861)
23. Bochtler M., Ditzel L., Groll M., Hartmann C., Huber R. 1999. The proteasome. Annu. Rev. Biophys. Biomol. Struct. 28 : 295-317.
24. Bose S., Brooks P., Mason G. G., Rivett A. J. 2001. Gamma-interferon decreases the level of 26 S proteasomes and changes the pattern of phosphorylation. Biochem. J. 353 : 291-297. (Pubitemid 32096938)
25. Bose S., Mason G. G., Rivett A. J. 1999. Phosphorylation of proteasomes in mammalian cells. Mol. Biol. Rep. 26 : 11-14. (Pubitemid 29223244)
26. Bose S., Stratford F. L., Broadfoot K. I., Mason G. G., Rivett A. J. 2004. Phosphorylation of 20S proteasome alpha subunit C8 (alpha7) stabilizes the 26S proteasome and plays a role in the regulation of proteasome complexes by gamma-interferon. Biochem. J. 378 : 177-184. (Pubitemid 38299555)
27. Bowerman B., Kurz T. 2006. Degrade to create: developmental requirements for ubiquitin-mediated proteolysis during early C. Elegans embryogenesis. Development. 133 : 773-784.
28. Brannigan J. A., Dodson G., Duggleby H. J., Moody P. C., Smith J. L., Tomchick D. R., Murzin A. G. 1995. A protein catalytic framework with an N-terminal nucleophil is capable of self-activation. Nature. 378 : 416-419.
29. Braun B. C., Glickman M., Kraft R., Dahlmann B., Kloet- zel P. M., Finley D., Schmidt M. 1999. The base of the proteasome regulatory particle exhibits chaperone-like activity. Nat. Cell. Biol. 1 : 221-226. (Pubitemid 129500941)
30. Breitschopf K., Haendeler J., Malchow P., Zeiher A.M., Dimmeler S. 2000a. Posttranslational modification of Bcl - 2 facilitates its proteasome-dependent degradation: molecular characterization of the involved signaling pathway. Mol. Cell. Biol. 20 : 1886-1896. (Pubitemid 30100205)
31. Breitschopf K., Zeiher A. M., Dimmeler S. 2000b. Ubiquitin-mediated degradation of the proapoptotic active form of bid. A functional consequence on apoptosis induction. J. Biol. Chem. 275 : 21 648 - 21 652. (Pubitemid 30481872)
32. Briggs S. D., Xiao T., Sun Z. W., Caldwell J. A., Shabanowitz J., Hunt D. F., Allis C. D., Strahl B. D. 2002. Gene silencing: trans-histone regulatory pathway in chromatin. Nature. 418 : 498.
33. Burns T. F., El Deiry W. S. 1999. The p53 pathway and apoptosis. J. Cell. Physiol. 181 : 231-239.
34. Burri L., Höckendorff J., Boehm U., Klamp T., Dohmen R. J., Levy F. 2000. Identification and characterization of a mammalian protein interacting with 20S proteasome precursors. Proc. Nat. Acad. Sci. USA. 97 : 10 348 - 10 353.
35. Canu N., Barbato C., Ciotti M. T., Serafino A., Dus L., Calissano P. 2000. Proteasome involvement and accumulation of ubiquitinated proteins in cerebellar granule neurons undergoing apoptosis. J. Neurosci. 20 : 589-599. (Pubitemid 30225561)
36. Castaño J. G., Mahillo E., Arizti P., Arribas J. 1996. Phosphorylation of C8 and C9 subunits of the multicatalytic proteinase by casein kinase II and identification of the C8 phosphorylation sites by direct mutagenesis. Biochemistry. 35 : 3782-3789. (Pubitemid 26102167)
37. Chang Y. C., Lee Y. S., Tejima T., Tanaka K., Omura S., He- intz N. H., Mitsui Y., Magae J. 1998. mdm2 and bax, downstream mediators of the p53 response, are degraded by the ubiquitin-proteasome pathway. Cell. Growth Differ. 9 : 79-84. (Pubitemid 28049530)
38. Cho J. W., Park J. C., Lee J. C., Kwon T. K., Park J. W., Baek W.K., Suh S. I., Suh M. H. 2001. The levels of MDM2 protein are decreased by a proteasomemediated proteolysis prior to caspase-3-dependent pRb and PARP cleavages. J. Korean Med. Sci. 16 : 135-139.
39. Ciechanover A., Brundin P. 2003. The ubiquitin proteasome system in neurodegenerative diseases: sometimes the chicken, sometimes the egg. Neuron. 40 : 427-446. (Pubitemid 37244106)
40. Ciechanover A., Schwartz A.L. 2004. The ubiquitin system: pathogenesis of human diseases and drug targeting. Biochim. biophys. acta. 1695 : 3-17. (Pubitemid 39574964)
41. Clarke D. J., Diaz-Martinez L. A., Giménez-Abian J. F. 2005. Anaphase promoting complex or cyclosome? Cell Cycle. 4 : 1585-1592.
42. Claverol S., Burlet-Schiltz O., Girbal-Neuhauser E., Gairin J. E., Monsarrat B. 2002. Mapping and structural dissection of human 20 S proteasome using proteomic approaches. Mol. Cell. Proteomics. 1 : 567-578.
43. Coffino P. 2001. Antizyme, a mediator of ubiquitin-independent proteasomal degradation. Biochimie. 83 : 319-323. (Pubitemid 32293652)
44. Collins G.A., Tansey W.P. 2006. The proteasome: a utility tool for transcription? Curr. Opin. Genet. Develop. 16 : 197-202.
45. Coux O., Nothwang H. G., Silva Pereira I., Recillas Targa F., Bey F., Scherrer K. 1994. Phylogenic relationships of the amino acid sequences of prosome (proteasome, MCP) subunits. Mol. Gen. Genet. 245 : 769-780.
46. Dahlmann B. 2005. Proteasomes. Essays Biochem. 41 : 31-48. (Pubitemid 41500969)
47. Dahlmann B., Ruppert T., Kloetzel P. M., Kuehn L. 2001. Subtypes of 20S proteasomes from skeletal muscle. Biochimie 83 : 295-299. (Pubitemid 32293649)
48. Dallaporta B., Pablo M., Maisse C., Daugas E., Loeffler M., Zamzami N., Kroemer G. 2000. Proteasome activation as a critical event of thymocyte apoptosis. Cell. Death. Differ. 7 : 368-373. (Pubitemid 30209664)
49. Dawson S. P., Arnold J. E., Mayer N. J., Reynolds S. E., Billett M. A., Gordon C., Colleaux L., Kloetzel P. M., Tanaka K., Mayer R. J. 1995. Developmental changes of the 26 S proteasome in abdominal intersegmental muscles of Manduca sexta during programmed cell death. J. Biol. Chem. 270 : 1850-1858.
50. Delic J., Masdehors P., Omura S., Cosset J. M., Dumont J., Binet J. L., Magdelenat H. 1998. The proteasome inhibitor lactacystin induces apoptosis and sensitizes chemo- and radioresistant human chronic lymphocytic leukaemia lymphocytes to TNFalpha-initiated apoptosis. Br. J. Canc. 77 : 1103-1107. (Pubitemid 28116281)
51. Demartino G. N., Slaughter C. A. 1999. The proteasome, a novel protease regulated by multiple mechanisms. J. Biol. Chem. 274 : 22 123 - 22 126. (Pubitemid 129529211)
52. Demasi M., Shringarpure R., Davies K. J. 2001. Glutathiolation of the proteasome is enhanced by proteolytic inhibitors. Arch. Biochem. Biophys. 389 : 254-263. (Pubitemid 32881951)
53. Demasi M., Silva G. M., Netto L. E. 2003. 20 S proteasome from Saccharomyces cerevisiae is responsive to redox modifications and is S-glutathionylated. J. Biol. Chem. 278 : 679-685.
54. Deshaies R. J. 1995. Make it or break it: the role of ubiquitin-dependent proteolysis in cellular regulation. Trends Cell Biol. 5 : 428-434.
55. Deveraux Q. L., Roy N., Stennicke H. R., Van Arsdale T., Zhou Q., Srinivasula S. M., Alnemri E. S., Salvesen G. S., Reed J. C. 1998. IAPs block apoptotic events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases. EMBO J. 17 : 2215-2223.
56. Deveraux Q. L., Takahashi R., Salvesen G. S., Reed J. C. 1997. X-linked IAP is a direct inhibitor of cell-death proteases. Nature. 388 : 300-304.
57. Devoy A., Soane T., Welchman R., Mayer R. J. 2005. The ubiquitin-proteasome system and cancer. Essays Biochem. 41 : 187-203.
58. Dhananjayan S. C., Ismail A., Nawaz Z. 2005. Ubiquitin and control of transcription. Essays Biochem. 41 : 69-80.
59. Dick L. R., Moomaw C. R., Pramanik B. C., DeMartino G. N., Slaughter C. A. 1992. Identification and localization of a cysteinyl residue critical for the trypsin-like catalytic activity of the proteasome. Biochemistry. 31 : 7347-7355.
60. Dimmeler S., Breitschopf K., Haendeler J., Zeiher A. M. 1999. Dephosphorylation targets Bcl-2 for ubiquitin-dependent degradation: a link between the apoptosome and the proteasome pathway. J. Exp. Med. 189 : 1815-1822.
61. Distelhorst C. W. 2002. Recent insights into the mechanism of glucocorticosteroid-induced apoptosis. Cell Death Differ. 9 : 6-19.
62. Drexler H. C. 1997. Activation of the cell death program by inhibition of proteasome function.Proc. Nat. Acad. Sci. USA. 94 : 855-860.
63. Drexler H. C. A. 1998. Programmed cell death and the proteasome. Apoptosis. 3 : 1-7.
64. Drexler H. C., Risau W., Konerding M. A. 2000. Inhibition of proteasome function induces programmed cell death in proliferating endothelial cells. FASEB J. 14 : 65-77.
65. Duckett C. S., Nava V. E., Gedrich R. W., Clem R. J., Van Dongen J. L., Gilfillan M. C., Shiels H., Hardwick J. M., Thompson C. B. 1996. A conserved family of cellular genes related to the baculovirus iap gene and encoding apoptosis inhibitors. EMBO J. 15 : 2685-2694.
66. Etlinger J. D., Goldberg A. L. 1977. A soluble ATP-dependent proteolytic system responsible for the degradation of abnormal proteins in reticulocytes. Proc. Nat. Acad. Sci. USA. 74 : 54-58.
67. Eytan E., Moshe Y., Braunstein I., Hershko A. 2006. Roles of the anaphase-promoting complex/cyclosome and of its activator Cdc20 in functional substrate binding. Proc. Nat. Acad. Sci. USA. 103 (7) : 2081-2086.
68. Ezhkova E., Tansey W. P. 2004. Proteasomal ATPases link ubiquitylation of histone H2B to methylation of histone H3. Mol. Cell. 13 : 435-442.
69. Fang S., Jensen J. P., Ludwig R. L., Vousden K. H., Weissman A. M. 2000. Mdm2 is a RING finger-dependent ubiquitin protein ligase for itself and p53. J. Biol. Chem. 275 : 8945-8951.
70. Farout L., Mary J., Vinh J., Szweda L. I., Friguet B. 2006. Inactivation of the proteasome by 4-hydroxy-2-nonenal is site specific and dependant on 20S proteasome subtypes. Arch. Biochem. Biophys. 453 : 135-142.
71. Ferdous A., Gonzalez F., Sun L., Kodadek T., Johnston S. A. 2001. The 19S regulatory particle of the proteasome is required for efficient transcription elongation by RNA polymerase II. Mol. Cell. 7 : 981-991.
72. Ferdous A., Kodadek T., Johnston S.A. 2002. A nonproteolytic function of the 19S regulatory subunit of the 26S proteasome is required for efficient activated transcription by human RNA polymerase II. Biochemistry. 41 : 12 798 - 12 805.
73. Ferdous A., Sikder D., Gillette T., Nalley K., Kodadek T., Johnston S. A. 2007. The role of the proteasomal ATPases and activator monoubiquitylation in regulating Gal4 binding to promoters. Genes Develop. 21 : 112-123.
74. Fernandez Murray P., Biscoglio M. J., Passeron S. 2002. In vivo and in vitro phosphorylation of Candida albicans 20S proteasome. Arch. Biochem. Biophys. 404 : 116-125.
75. Figueiredo-Pereira M. E., Chen W. E., Yuan H. M., Wilk S. 1995. A novel chymotrypsin-like component of the multicatalytic proteinase complex optimally active at acidic pH. Arch. Biochem. Biophys. 317 : 69-78.
76. Finley D., Tanaka C., Mann C., Feldmann M., Hochstrasser M., Vierstra R., Johnson S., Hampton R., Haber J., Mccusker J. 1998. Unified nomenclature for subunits of the Saccharomyces cerevisiae proteasome regulatory particle. Trends Biochem. Sci. 23 : 244-245.
77. Franco A. V., Zhang X. D., Van Berkel E., Sanders J. E., Zhang X. Y., Thomas W. D., Nguyen T., Hersey P. 2001. The role of NF-kappa B in TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis of melanoma cells. J. Immunol. 166 : 5337-5345.
78. Fraser R. A., Rossignol M., Heard D. J., Egly J. M., Chambon P. 1997. SUG1, a putative transcriptional mediator and subunit of the PA700 proteasome regulatory complex, is a DNA helicase. J. Biol. Chem. 272 : 7122-7126.
79. Früh K., Gossen M., Wang K., Bujard H., Peterson P. A., Yang Y. 1994. Displacement of housekeeping proteasome subunits by MHC-encoded LMPs: a newly discovered mechanism for modulating the multicatalytic proteinase complex. EMBO J. 13 : 3236-3244.
80. Fu H. Y., Reis N., Lee Y., Glickman M. H., Vierstra R. 2001. Subunit interaction maps for the regulatory particle of the 26S proteasome and the COP9 signalosome reveal a conserved core structure. J. EMBO. 20 : 7096-7107.
81. Fujihara S., Ward C., Dransfield I., Hay R., Uings I., Hayes B., Farrow S., Haslett C., Rossi A. 2002. Inhibition of nuclear factor-κB activation un-masks the ability of TNF-α to induce human eosinophil apoptosis. Eur. J. Immunol. 32 : 457-466.
82. Fujita E., Mukasa T., Tsukahara T., Arahata K., Omura S., Momoi T. 1996. Enhancement of CPP32-like activity in the TNF-treated U937 cells by the proteasome inhibitors. Biochem. Biophys. Res. Commun. 224 : 74-79.
83. Gao G., Luo H. 2006. The ubiquitin-proteasome pathway in viral infections. Can. J. Physiol. Pharmacol. 84 : 5-14.
84. Gao X., Li J., Pratt G., Wilk S., Rechsteiner M. 2004. Purification procedures determine the proteasome activation properties of REGγ (PA28γ). Arch. Biochem. Biophys. 425 : 158-164.
85. Gautier-Bert K., Murol B., Jarrousse A. S., Ballut L., Badaoui S., Petit F., Schmid H. P. 2003. Substrate affinity and substrate specificity of proteasomes with RNase activity. Mol. Biol. Rep. 30 : 1-7.
86. Gillette T. G., Gonzalez F., Delahodde A., Johnston S. A., Kodadek T. 2004. Physical and functional association of RNA polymerase II and the proteasome. Proc. Nat. Acad. Sci. USA. 101 : 5904-5909.
87. Gillette T. G., Huang W., Russell S. J., Reed S. H., Johnston S. A., Friedberg E. C. 2001. The 19S complex of the proteasome regulates nucleotide excision repair in yeast. Genes Develop. 15 : 1528-1539.
88. Gillette T. G., Yu S., Zhou Z., Waters R., Johnston S. A., Reed S. H. 2006. Distinct functions of the ubiquitin-proteasome pathway influence nucleotide excision repair. EMBO J. 25 : 2529-2538.
89. Glickman M. H., Ciechanover A. 2002. The ubiquitin - proteasome proteolytic pathway: destruction for the sake of construction. Physiol. Rev. 82 : 373-428.
90. Glickman M. H., Raveh D. 2005. Proteasome plasticity. FEBS Lett. 579 : 3214-3223.
91. Glickman M. H., Rubin D. M., Coux O., Wefes I., Pfeifer G., Cjeka Z., Baumeister W., Fried V. A., Finley D. 1998. A subcomplex of the proteasome regulatory particle required for ubiquitin-conjugate degradation and related to the COP9-signalosome and eIF3. Cell. 94 : 615-623.
92. Gomes A. V., Zong C., Edmondson R. D., Li X., Stefani E., Zhang J, Jones R. C., Thyparambil S., Wang G. W, Qiao X., Bardag-Gorce F., Ping P. 2006. Mapping the murine cardiac 26S proteasome complexes. Circ. Res. 99 (4) : 362-371.
93. Gregory M. A., Hann S. R. 2000. c-Myc proteolysis by the ubiquitin - proteasome pathway: stabilization of c-Myc in Burkitt's lymphoma cells. Mol. Cell. Biol. 20 : 2423-2435.
94. Grimm L. M., Goldberg A. L., Poirier G. G., Schwartz L. M., Osborne B. A. 1996. Proteasomes play an essential role in thymocyte apoptosis. EMBO J. 15 : 3835-3844.
95. Groettrup M., Khan S., Schwarz K., Schmidtke G. 2001a. Interferon-gamma inducible exchanges of20S proteasome active site subunits: why? Biochimie. 83 : 367-372.
96. Groettrup M., van den Broek M., Schwarz K., Macagno A., Khan S., de Giuli R., Schmidtke G. 2001b. Structural plasticity of the proteasome and its function in antigen processing. Crit. Rev. Immunol. 21 : 339-358.
97. Groll M., Bochtler M., Brandstetter H., Clausen T., Huber R. 2005. Molecular machines for protein degradation. Chembiochem. 6 : 222-256.
98. Groll M., Ditzel L., Löwe J., Stock D., Bochtler M., Bartunik H. D., Huber R. 1997. Structure of 20S proteasome from yeast at 2.4 Å resolution. Nature. 386 : 463-471.
99. Groll M., Huber R. 2004. Inhibitors of the eukaryotic 20S proteasome core particle: a structural approach. Biochim. biophys. acta. 1695 : 33-44.
100. Haass C., Kloetzel P. M. 1989. The Drosophila proteasome undergoes changes in its subunit pattern during development. Exp. Cell. Res. 180 : 243-252.
101. Hatakeyama S., Yada M., Matsumoto M., Ishida N., Nakayama K. 2001. U box proteins as a new family of ubiquitin-protein ligases. J. Biol. Chem. 276 : 33 111 - 33 120.
102. Heinemeyer W., Fischer M., Krimmer T., Stachon U., Wolf D. H. 1997. The active sites of the eukaryotic 20 S proteasome and their involvement in subunit precursor processing. J. Biol. Chem. 272 : 25 200 - 25 209.
103. Heinemeyer W., Ramos P. C., Dohmen R. J. 2004. The ultimate nanoscale mincer: assembly, structure and active sites of the 20S proteasome core. Cell Mol. Life Sci. 61: 1562-1578.
104. Heink S., Ludwig D., Kloetzel P.M., Kruger E. 2005. IFN-gamma-induced immune adaptation of the proteasome system is an accelerated and transient response. Proc. Nat. Acad. Sci. USA. 102 : 9241-9246.
105. Hendil K. B., Khan S., Tanaka K. 1998. Simultaneous binding of PA28 and PA700 activators to 20S proteasomes. Biochem. J. 332 : 749-754.
106. Herrmann J. L., Briones F. J., Brisbay S., Logothetis C. J., McDonnell T. J. 1998. Prostate carcinoma cell death resulting from inhibition of proteasome activity is independent of functional Bcl-2 and p53. Oncogene. 17 : 2889-2899.
107. Herrmann J., Ciechanover A., Lerman O., Lerman A. 2004. The ubiquitin-proteasome system in cardiovascular diseases - a hypothesis extended. Cardiovascular Res. 61 : 11-12.
108. Hershko A. 1997. Roles of ubiquitin-mediated proteolysis in cell cycle control. Curr. Opin. Cell Biol. 9 : 788-799.
109. Hershko A., Ciechanover A. 1998. The ubiquitin system. Annu. Rev. Biochem. 67 : 425-479.
110. Hershko A., Ciechanover A., Varshavsky A. 2000. Basic medical research award. The ubiquitin system. Nat. Med. 6 : 1073-1081.
111. Hirsch T., Dallaporta B., Zamzami N., Susin S. A., Ravag- nan L., Marzo I., Brenner C., Kroemer G. 1998. Proteasome activation occurs at an early, premitochondrial step of thymocyte apoptosis. J. Immunol. 161 : 35-40.
112. Hochshtrasser M. 1996. Ubiquitin-dependent protein degradation. Annu. Rev. Immunol. 17 : 405-439.
113. Hoppe T. 2005. Multiubiquitylation by E4 enzymes: «one size» doesn't fit all. Trends Biochem. Sci. 30 : 183-187.
114. Horiguchi R., Yoshikuni M., Tokumoto M., Nagahama Y., Tokumoto T. 2005. Identification of a protein kinase which phosphorylates a subunit of the 26S proteasome and changes in its activity during meiotic cell cycle in goldfish oocytes. Cell Signal. 17 : 205-215.
115. Hoyt M. A., Coffino P. 2004. Ubiquitin-free routes into the proteasome. Cell Mol. Life Sci. 61 : 1596-1600.
116. Hughes A. L. 1997. Evolution of the proteasome components. Immunogenetics. 46 : 82-92.
117. Humbard M. A., Stevens S. M., Jr., Maupin-Furlow J. A. 2006. Posttranslational modification of the 20S proteasomal proteins of the archaeon Haloferax volcanii. J. Bacteriol. 188 : 7521-7530.
118. Ichihara A., Tanaka K., Andoh T., Shimbara N. 1993. Regulation of proteasome expression in developing and transformed cells. Adv. Enzyme Regul. 33 : 173-180.
119. Imajoh-Ohmi S., Kawaguchi T., Sugiyama S., TanakaK., Omura S., Kikuchi H. 1995. Lactacystin, a specific inhibitor of the proteasome, induces apoptosis in human monoblast U937 cells. Biochem. Biophys. Res. Commun. 217 : 1070-1077.
120. Iwafune Y., Kawasaki H., Hirano H. 2002. Electrophoretic analysis of phosphorylation of the yeast 20S proteasome. Electrophoresis. 23 : 329-338.
121. Iwafune Y., Kawasaki H., Hirano H. 2004. Identification of three phosphorylation sites in the alpha7 subunit of the yeast 20S proteasome in vivo using mass spectrometry. Arch. Biochem. Biophys. 431 : 9-15.
122. Jariel-Encontre I., Bossis G., Piechaczyk M. 2008. Ubiquitin-independent degradation of proteins by the proteasome. Biochim. biophys. acta. 1786 : 153-177.
123. Jariel-Encontre I., Pariat M., Martin F., Carillo S., Salvat C., Piechaczyk M. 1995. Ubiquitinylation is not an absolute requirement for degradation of c-Jun protein by the 26 S proteasome. J. Biol. Chem. 270 : 11 623 - 11 627.
124. Jarrousse A. S., Petit F., Kreutzer-Schmid K., Gaedigk R., Schmid H. P. 1999. Possible involvement of proteasomes (prosomes) in AUUUA-mediated mRNA decay. J. Biol. Chem. 274 : 22 023 - 22 028.
125. Jin J., AngX. L., Shirogane T., Wade Harper J. 2005. Identification of substrates for F-box proteins. Methods Enzymol. 399 : 287-309.
126. Joazeiro C. A., Weissman A. M. 2000. RING finger proteins: mediators of ubiquitin ligase activity. Cell. 102 : 549-552.
127. Johnson D. G., Walker C. L. 1999. Cyclins and cell cycle checkpoints. Annu. Rev. Pharmacol. Toxicol. 39 : 295-312.
128. Jones M. E., Haire M. F., Kloetzel P. M., Mykles D. L., Schwartz L. M. 1995. Changes in the structure and function of the multicatalytic proteinase (proteasome) during programmed cell death in the intersegmental muscles of the hawkmoth, Manduca sexta. Develop. Biol. 169 : 436-447.
129. Josefsberg L. B., Galiani D., Dantes A., Amsterdam A., Dekel N. 2000. The proteasome is involved in the first metaphase-to-anaphase transition of meiosis in rat oocytes. Biol. Reprod. 62 : 1270-1277.
130. JosefsbergL. B., Kaufman O., Galiani D., Kovo M., Dekel N. 2001. Inactivation of M-phase promoting factor at exit from first embryonic mitosis in the rat is independent of cyclin B1 degradation. Biol. Reprod. 64 : 871-878.
131. Kanayama H., Tanaka K., Aki M., Kagawa S., Miyaji H., Satoh M., Okada F., Sato S., Shimbara N., Ichihara A. 1991. Changes in expressions of proteasome and ubiquitin genes in human renal cancer cells. Cancer Res. 51 : 6677-6685.
132. Karin M., Ben-Neriah Y. 2000. Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. Annu. Rev. Immunol. 18 : 621-663.
133. Kawahara H., Kasahara M., Nishiyama A., Ohsumi K., Goto T., Kishimoto T., Saeki Y., Yokosawa H., Shimbara N., Murata S., Chiba T., Suzuki K., Tanaka K. 2000a. Developmentally regulated, alternative splicing of the Rpn10 gene generates multiple forms of 26S proteasomes. EMBO J. 19 : 4144-4153.
134. Kawahara H., Philipova R., Yokosawa H., Patel R., Tanaka K., Whitaker M. 2000b. Inhibiting proteasome activity causes overreplication of DNA and blocks entry into mitosis in sea urchin embryos. J Cell Sci. 113 : 2659-2670.
135. Kessel M., Wu W., Gottesman S., Kocsis E., Steven A. C., Maurizi M. R. 1996. Six-fold rotational symmetry of ClpQ, the E. coli homolog of the 20S proteasome, and its ATP-dependent activator, ClpY. FEBS Lett. 398 : 274-278.
136. Kile B.T., Schulman B.A., Alexander W.S., Nicola N.A., Martin H.M., Hilton D.J. 2002. The SOCS box: a tale of destruction and degradation.Trends Biochem. Sci. 27: 235-241.
137. Kimura Y., Saeki Y., Yokosawa H., Polevoda B., Sherman F., Hirano H. 2003. N-terminal modifications of the 19S regulatory particle subunits of the yeast proteasome. Arch. Biochem. Biophys. 409 : 341-348.
138. Kimura Y., Takaoka M., Tanaka S., Sassa H., Tanaka K., Polevoda B., Sherman F., Hirano H. 2000. N-acetylation and proteolytic activity of the yeast 20 S proteasome. J. Biol. Chem. 275 : 4635-4639.
139. King R. W., Deshaies R. J., Peters J.-M., Kirschner M. W. 1996. How the proteolysis drives the cell cycle. Science. 274 : 1652-1659.
140. Kinyamu H. K., Archer T. K. 2007. Proteasome activity modulates chromatin modifications and RNA polymerase II phosphorylation to enhance glucocorticoid receptor-mediated transcription. Mol. Cell. Biol. 27 : 4891-4904.
141. Kinyamu H.K., Chen J., Archer T.K. 2005. Linking the ubiquitin - proteasome pathway to chromatin remodeling/modification by nuclear receptors. J. Mol. Endocrinol. 34 : 281-297.
142. Kitagawa H., Tani E., Ikemoto H., Ozaki I., Nakano A., Omura S. 1999. Proteasome inhibitors induce mitochondria-independent apoptosis in human glioma cells. FEBS Lett. 443 : 181-186.
143. Kiyomiya K., Kurebe M., Nakagawa H., Matsuo S. 2002. The role of the proteasome in apoptosis induced by anthracycline anticancer agents. Int. J. Oncol. 20 : 1205-1259.
144. Klein U., Gernold M., Kloetzel P. M. 1990. Cell-specific accumulation of Drosophila proteasomes (MCP) during early development. J. Cell. Biol. 111 : 2275-2282.
145. Kloetzel P. M. 2001. Antigen processing by the proteasome. Nat. Rev. Mol. Cell. Biol. 2 : 179-187.
146. Kloetzel P. M. 2004. The proteasome and MHC class I antigen processing. Biochim. biophys. acta. 1695 : 225-233.
147. Kloetzel P. M., Soza A., Stohwasser R. 1999. The role of the proteasome system and the proteasome activator PA28 complex in the cellular immune response. Biol. Chem. 380 : 293-297. (Pubitemid 29145942)
148. Knuehl C., Seelig A., Brecht B., Henklein P., Kloetzel P. M. 1996. Functional analysis of eukaryotic 20S proteasome nuclear localization signal.Exp. Cell Res. 225 (1) : 67-74. (Pubitemid 26158456)
149. Krogan N. J., Lam M. H. Y., Fillingham J., Keogh M. C., Gebbia M., Li J., Datta N., Cagney G., Buratowski S., Emili A., Greenblatt J. F. 2004. Proteasome involvement in the repair of DNA Double-strand breaks. Mol. Cell. 16 : 1027-1034. (Pubitemid 40018411)
150. Kumatori A., Tanaka K., Inamura N., Sone S., Ogura T., Matsumoto T., Tachikawa T., Shin S., Ichihara A. 1990. Abnormally high expression of proteasomes in human leukemic cells. Proc. Nat. Acad. Sci. USA. 87 : 7071-7075. (Pubitemid 20325208)
151. Kumeda S. I., Deguchi A., Toi M., Omura S., Umezawa K. 1999. Induction of G1 arrest and selective growth inhibition by lactacystin in human umbilical vein endothelial cells. Anticancer Res. 19 : 3961-3968.
152. Kuttler C., Nussbaum A. K., Dick T. P., Rammensee H. G., Schild H., Hadeler K. P. 2000. An algorythm for the prediction of proteasomal cleavages. J. Mol. Biol. 298 : 417-429.
153. Lee D., Ezhkova E., Li B., Pattenden S.G., TanseyW.P., Workman J. L. 2005. The proteasome regulatory particle alters the SAGA coactivator to enhance its interactions with transcriptional activators. Cell. 123 : 423-436. (Pubitemid 41546673)
154. Lee M., Hyun D. H., Marshall K. A., Ellerby L. M., Bredesen D. E., Jenner P., Halliwell B. 2001. Effect of overexpression of Bcl-2 on cellular oxidative damage, nitric oxide production, antioxidant defenses, and the proteasome. Free Radic. Biol. Med. 31 : 1550-1559. (Pubitemid 34024977)
155. Lee S. C., Shaw B. D. 2007. A novel interaction between N-myristoylation and the 26S proteasome during cell morphogenesis. Mol. Microbiol. 63 : 1039-1053.
156. Lehmann A., Janek K., Braun B., Kloetzel P. M., Enenkel C. 2002. 20S proteasomes are imported as precursor complexes into the nucleus of yeast. J. Mol. Biol. 317 : 401-413. (Pubitemid 34722179)
157. Li B., Dou Q. P. 2000. Bax degradation by the ubiquitin/proteasome- dependent pathway: involvement in tumor survival and progression. Proc. Nat. Acad. Sci. USA. 97 : 3850-3855. (Pubitemid 30226050)
158. Li N., Lerea K. M., Etlinger J. D. 1996. Phosphorylation of the proteasome activator PA28 is required for proteasome activation. Biochem. Biophys. Res. Commun. 225 : 855-860. (Pubitemid 26319195)
159. Lipford J. R., Deshaies R. J. 2003. Diverse roles for ubiquitin-dependent proteolysis in transcriptional activation. Nature Cell Biol. 5 : 845-850.
160. Lipford J. R., Smith G. T., Chi Y., Deshaies R. J. 2005. A putative stimulatory role for activator turnover in gene expression. Nature. 438 : 113-116. (Pubitemid 41599830)
161. Liu C.-W., Corboy M.J., DeMartino G. N., Thomas P. J. 2003. Endoproteolytic activity of the proteasome. Science. 299 : 408-411.
162. Lommel L., Ortolan T., Chen L., Madura K., Sweder K. S. 2002. Proteolysis of a nucleotide excision repair protein by the 26S proteasome. Curr. Genet. 42 : 9-20. (Pubitemid 36075988)
163. Löw P., Bussell K., Dawson S. P., Billett M. A., Mayer R. J., Reynolds S. E. 1997. Expression ofa 26S proteasome ATPase subunit, MS73, in muscles that undergo developmentally programmed cell death, and its control by ecdysteroid hormones in the insect Manduca sexta. FEBS Lett. 400 : 345-349. (Pubitemid 27039381)
164. Lowe J., Stock D., Jap B., Zwickl P., Baumeister W., Huber R. 1995. Crystal structure of the 20S proteasome from the archaeon T. acidophilum at 3.4 Å resolution. Science. 268 : 533-539.
165. Ludemann R., Lerea K. M., Etlinger J. D. 1993. Copurification of casein kinase II with 20S proteasomes and phosphorylation of a 30-kDa proteasome subunit. J. Biol. Chem. 268 : 17413-17417. (Pubitemid 23236982)
166. Luo H., Wu Y., Qi S., Wan X., Chen H., Wu J. 2001. A proteasome inhibitor effectively prevents mouse heart allograft rejection. Transplantation. 72 : 196-202. (Pubitemid 32729334)
167. Machiels B. M., Henfling M. E., Gerards W. L., Broers J. L., Bloemendal H., Ramaekers F. C. Schutte B. 1997. Detailed analysis of cell cycle kinetics upon proteasome inhibition. Cytometry. 28 : 243-252. (Pubitemid 27294713)
168. Machiels B. M., Henfling M. E., Schutte B., van Engeland M., Broers J. L., Ramaekers F. C. 1996. Subcellular localization of proteasomes in apoptotic lung tumor cells and persistence as compared to intermediate filaments. Eur. J.
169. MacLaren A. P., Chapman R. S., Wyllie A. H., Watson C. J. 2001. p53-dependent apoptosis induced by proteasome inhibition in mammary epithelial cells. Cell Death Differ. 8 : 210-218. (Pubitemid 32288166)
170. Makino Y., Yoshida T., Yogosawa S., Tanaka K., Muramatsu M., Tamura T. A. 1999. Multiple mammalian proteasomal ATPases, but not proteasome itself, are associated with TATA-binding protein and a novel transcriptional activator, TIP120. Genes Cells. 4 : 529-539. (Pubitemid 29521204)
171. Martin M. C., Dransfield I., Haslett C., Rossi A. G. 2001. Cyclic AMP regulation of neutrophil apoptosis occurs via a novel PKA-independent signaling pathway. J. Biol. Chem. 276 (48) : 45 041 - 45 050. (Pubitemid 37391295)
172. Mason G. G., Hendil K. B., Rivett A. J. 1996. Phosphorylation of proteasomes in mammalian cells. Identification of two phospho-rylated subunits and the effect of phosphorylation on activity. Eur. J. Biochem. 238 : 453-462. (Pubitemid 126425462)
173. Mason G., Murray R., Pappin D., Rivett A. J. 1998. Phosphorylation of ATPase subunits of the 26S proteasome. FEBS. 430 : 269-274. (Pubitemid 28337927)
174. Masson P., Andersson O., Petersen U. M., Young P. 2001. Identification and characterization of a Drosophila nuclear protea-some regulator. A homolog of human 11 S REGgamma (PA28gamma ). J. Biol. Chem. 276 : 1383-1390. (Pubitemid 32096569)
175. Maupin-Furlow J. A., Aldrich H. C., Ferry J. G. 1998. Biochemical characterization of the 20S proteasome from the methanoarchaeon Methanosarcina thermophila. J. Bacteriol. 180 : 1480-1487.
176. Maupin-Furlow J. A., Humbard M. A., Kirkland P. A., Li W., Reuter C. J., Wright A. J., Zhou G. 2006. Proteasomes from structure to function: perspectives from Archaea. Curr. Top. Develop. Biol. 75 : 125-169. (Pubitemid 44375084)
177. Mayr J., Seemuller E., Muller S. A., Engel A., Baumeister W. 1998. Late events in the assembly of 20S proteasomes. J. Struct. Biol. 124 : 179-188. (Pubitemid 29143059)
178. Murakami Y., Matsufuji S., Kameji T., Hayashi S., Igarashi K., Tamura T., Tanaka K., Ichihara A. 1992. Ornithine decarboxylase is degraded by the 26S proteasome without ubiquitination. Nature. 360 : 597-599. (Pubitemid 23000711)
179. Murata S. 2006. Multiple chaperone-assisted formation of mammalian 20S proteasomes. IUBMB Life. 58 : 344-348.
180. Muratani M., Tansey W. P. 2003. How the ubiquitin-proteasome system controls transcription. Nat. Rev. Mol. Cell Biol. 4 : 192-201.
181. Nandi D., Tahiliani P., Kumar A., Chandu D. 2006. Theubiquitin-proteasome system. J. Biosci. 31: 137-155.
182. Nandi D., Woodward E., Ginsburg D. B., Monaco J. J. 1997. Intermediates in the formation of mouse 20S proteasomes: implications for the assembly of precursor beta subunits. EMBO J. 16 : 5363-5375.
183. Naujokat C., Hoffmann S. 2002. Role and function of the 26S proteasome in proliferation and apoptosis. Lab. Invest. 82 : 965-980.
184. Naujokat C., Sezer O., Zinke H., Leclere A., Hauptmann S., Possinger K. 2000. Proteasome inhibitors induced caspase-dependent apoptosis and accumulation of p21WAF1/Cip1 in human immature leukemic cells. Eur. J. Haematol. 65 : 221-236.
185. Nawaz Z., O'Malley B. W. 2004. Urban renewal in the nucleus: is protein turnover by proteasomes absolutely required for nuclear receptor-regulated transcription? Mol. Endocrinol. 18 : 493-499.
186. Nederlof P. M., WangH. R., Baumeister W. 1995. Nuclear localization signals of human and Thermoplasma proteasomal alpha subunits are functional in vitro. Proc. Nat. Acad. Sci. USA. 92 : 12 060 - 12 064.
187. Nikaido T., Shimada K., Shibata M., Hata M., Sakamoto M., Takasaki Y., Sato C., Takahashi T., Nishida Y. 1990. Cloning and nucleotide sequence of cDNA for Ki antigen, a highly conserved nuclear protein detected with sera from patients with systemic lupus erythematosus. Clin. Exp. Immunol. 79 : 209-214.
188. Orlowski M., Wilk S. 2000. Catalytic activities of the 20S proteasome, a multicatalytic proteinase complex. Arch. Biochem. Biophys. 383 : 1-16.
189. Orlowski M., Wilk S. 2003. Ubiquitin-independent proteolytic functions of the proteasome. Arch. Biochem. Biophys. 415 : 1-5.
190. Orlowski R. Z., Eswara J. R., Lafond-Walker A., Grever M. R., Orlowski M., Dang C. V. 1998. Tumor growth inhibition induced in a murine model of human Burkitt's lymphoma by a proteasome inhibitor. Cancer Res. 58 : 4342-4348.
191. Pajonk F., McBride W. H. 2001. The proteasome in cancer biology and treatment. Radiat. Res. 156 : 447-459.
192. Palmer A., Rivett A. J., Thomson S., Hendil K. B., Butcher G. W., Fuertes G., Knecht E. 1996. Subpopulations of proteasomes in rat liver nuclei, microsomes and cytosol. Biochem. J. 316 : 401-407.
193. Pereira M. E., Yu B., Wilk S. 1992. Enzymatic changes of the bovine pituitary multicatalytic proteinase complex, induced by magnesium ions. Arch. Biochem. Biophys. 294 : 1-8.
194. Pereira M. E., Wilk S. 1990. Phosphorylation of the multicatalytic proteinase complex from bovine pituitaries by a copurifying cAMP-dependent protein kinase. Arch. Biochem. Biophys. 283 : 68-74.
195. Petit F., Jarrousse A.-S., Dahlmann B., Sobek A., Hendil K. B., Bury J., Briand Y., Schmid H.-P. 1997. Involvement of proteasomal subunits zeta and iota in RNA degradation. Biochem. J. 326 : 93-98.
196. Pickart C. M. 2001. Mechanisms underlying ubiquitination. Annu. Rev. Biochem. 70 : 503-533.
197. Pickart C. M., Eddins M. J. 2004. Ubiquitin: structures, functions, mechanisms. Biochim. biophys. acta. 1695 : 55-72.
198. Pleban E., Bury M., Mlynarczuk I., Wojcik C. 2001. Effects of proteasome inhibitor PSI on neoplastic and non-transformed cell lines. Folia Histochem. Cytobiol. 39 : 133-134.
199. Qiu J. H., Asai A., Chi S., Saito N., Hamada H., Kirino T. 2000. Proteasome inhibitors induce cytochrome c-caspase - 3-like protease-mediated apoptosis in cultured cortical neurons. J. Neurosci. 20 : 259-265.
200. Rajkumar S. V., Richardson P. G., Hideshima T., Anderson K. C. 2005. Proteasome inhibition as a novel therapeutic target in human cancer. J. Clin. Oncol. 23 : 630-639.
201. Ramos P. C., Höckendorff J., Johnson E. S., Varshavsky A., Dohmen R. J. 1998. Ump1p is required for proper maturation of the 20S proteasome and becomes its substrate upon completion of the assembly. Cell. 92 : 489-499.
202. Rao S., Porter D. C., Chen X., Herliczek T., Lowe M., Keyomarsi K. 1999. Lovastatin-mediated G1 arrest is through inhibition of the proteasome, independent of hydroxymethyl glutaryl-CoA reductase. Proc. Nat. Acad. Sci. USA. 96 : 7797-7802.
203. Rape M., Jentsch S. 2004. Productive RUPture: activation of transcription factors by proteasomal processing. Biochim. biophys. acta. 1695 : 209-213.
204. Realini C., Jensen C. C., Zhang Z., Johnston S. C., Knowlton J. R., Hill C. P., Rechsteiner M. 1997. Characterization of recombinant REGalpha, REGbeta, and REGgamma proteasome activators. J. Biol. Chem. 272 : 25 483 - 25 492.
205. Rechsteiner M., Hill C.P. 2005. Mobilizing the proteolytic machine: cell biological roles of proteasome activators and inhibitors. Trends Cell Biol. 15 : 27-33.
206. Rechsteiner M., Hoffman L., Dubiel W. 1993. The multicatalytic and 26 S proteases. J. Biol. Chem. 268 : 6065-6068.
207. Rechsteiner M., Rogers S. W. 1996. PEST sequences and regulation by proteolysis. Trends Biochem. Sci. 21 : 267-271.
208. Reed S. H., Gillette T. G. 2007. Nucleotide excision repair and the ubiquitin proteasome pathway - do all roads lead to Rome? DNA Repair (Amst.). 6 : 149-156.
209. Reed S. I. 2006. The ubiquitin-proteasome pathway in cell cycle control. Results Probl. Cell Differ. 42 : 147-181.
210. Reid J., Svejstrup J. Q. 2004. DNA damage-induced Def1- RNA polymerase II interaction and Def1 requirement forpolymerase ubiquitylation in vitro. J. Biol. Chem. 279 : 29 875 - 29 878.
211. Reverte C. G., Ahearn M. D., Hake L. E. 2001. CPEB degradation during Xenopus oocyte maturation requires a PEST domain and the 26S proteasome. Develop. Biol. 231 : 447-458.
212. Rivett A. J. 1998. Intracellular distribution of proteasomes. Curr. Opin. Immunol. 10 : 110-114.
213. Rivett A., Bose S., Brooks P., Broadfoot K. I. 2001. Regulation of proteasome complexes by γ-interferon and phosphorylation. Biochimie. 83 : 363-366.
214. Rivett A. J., Palmer A., Knecht E. 1992. Electron microscopic localization of the multicatalytic proteinase complex in rat liver and in cultured cells. J. Histochem. Cytochem. 40 : 1165-1172.
215. Rock K. L., Goldberg A. L. 1999. Degradation of cell proteins and the generation of MHC class I-presented peptides. Annu. Rev. Immunol. 17 : 739-779.
216. Rock K. L., Gramm C., Rothstein L., Clark K., Stein R., Dick L., Hwang D., Goldberg A. L. 1994. Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules. Cell. 78 : 761-771.
217. Rohrwild M., Coux O., Huang H. C., Moerschell R. P., Yoo S. J., Seol J. H. 1996. HslV-HslU: a novel ATP-dependent protease complex in Escherichia coli related to the eukaryotic proteasome. Proc. Nat. Acad. Sci. USA. 93 : 5808-5813.
218. Rohrwild M., Pfeifer G., Santarius U., Muller S. A., Hu- ang H. C., Engel A., Baumeister W., Goldberg A. L. 1997. The ATP-dependent HslVU protease from Escherichia coli is a four-ring structure resembling the proteasome. Nat. Struct. Biol. 4 : 133-139.
219. Russell S. J., Reed S. H., Huang W., Friedberg E. C., Johnston S. A. 1999. The 19S regulatory complex of the proteasome functions independently of proteolysis in nucleotide excision repair. Mol. Cell. 3 : 687-695.
220. Ryabova L. V., Virtanen I., Olink-Coux M., Scherrer K., Vas- setzky S. G. 1994. Distribution of prosome proteins and theirrelationship with the cytoskeleton in oogenesis of Xenopus laevis. Mol. Reprod. Develop. 37 : 195-203.
221. Sadoul R., Fernandez P. A., Quiquerez A. L., Martinou I., Maki M., Schroter M., Becherer J. D., IrmlerM., Tschopp J., Martinou J. C. 1996. Involvement of the proteasome in the programmed cell death of NGF-deprived sympathetic neurons. EMBO J. 15 : 3845-3852.
222. Salghetti S. E., Kim S. Y., Tansey W. P. 1999. Destruction of Myc by ubiquitin-mediated proteolysis: cancer-associated and transforming mutations stabilize Myc. EMBO J. 18 : 717-726.
223. Satoh K., Nishikawa T., Yokosawa H., Sawada H. 1995. Phosphorylation of proteasome substrate by a protein kinase associated with the 26 S proteasome is linked to the ATP-dependent proteolysis of the 26 S proteasome. Biochem. Biophys. Res. Commun. 213 : 7-14.
224. Sawada M. T., Morinaga C., Izumi K., Sawada H. 1999. The 26S proteasome assembly is regulated by a maturation-inducing hormone in starfish oocytes. Biochem. Biophys. Res. Commun. 254 : 338-344.
225. Schauber C., Chen L., Tongaonkar P., Vega I., Lambertson D., Potts W., Madura K. 1998. Rad23 links DNA repair to the ubiquitin/proteasome pathway. Nature. 391 : 715-718.
226. Schmidt M., Hanna J., Elsasser S., Finley D. 2005. Proteasome-associated proteins: regulation of a proteolytic machine. Biol. Chem. 386 : 725-737.
227. Schwechheimer C., Schwager K. 2004. Regulated proteolysis and plant development. Plant Cell Rep. 23 : 353-364.
228. Sexl V., Diehl J. A., Sherr C. J., Ashmun R., Beach D., Roussel M. F. 1999. A rate limiting function of cdc25A for S phase entry inversely correlates with tyrosine dephosphorylation of Cdk2. Oncogene. 18 : 573-582.
229. Shah S. A., Potter M. W., Callery M. P. 2001a. Ubiquitin proteasome pathway: implications and advances in cancer therapy. Surg. Oncol. 10 : 43-52.
230. Shah S. A., Potter M. W., McDade T. P., Ricciardi R., Perugi- ni R. A., Elliott P. J., Adams J., Callery M.P. 2001b. 26S proteasome inhibition induces apoptosis and limits growth of human pancreatic cancer. J. Cell. Biochem. 82 : 110-122.
231. Sheaff R. J., Singer J. D., Swanger J., Smitherman M., Roberts J. M., Clurman B. E. 2000. Proteasomal turnover of p21Cip1 does not require p21Cip1 ubiquitination. Mol. Cell. 5 : 403-410.
232. Shen Y., White E. 2001. p53-dependent apoptosis pathways. Adv. Cancer Res. 82 : 55-84.
233. Shibahara T., Kawasaki H., Hirano H. 2002. Identification of the 19S regulatory particle subunits from the rice 26S proteasome. Eur. J. Biochem. 269 : 1474-1483.
234. Shibahara T., Kawasaki H., Hirano H. 2004. Mass spectrometric analysis of expression of ATPase subunits encoded by duplicated genes in the 19S regulatory particle of rice 26S proteasome. Arch. Biochem. Biophys. 421 : 34-41.
235. Shibatani T., Ward W.F. 1995. Sodium dodecyl sulfate (SDS) activation of the 20S proteasome in rat liver. Arch. Biochem. Biophys. 321 : 160-166.
236. Shimbara N., Orino E., Sone S., Ogura T., Takashina M., Shono M., Tamura T., Yasuda H., Tanaka K., Ichihara A. 1992. Regulation of gene expression of proteasomes (multi-protease complexes) during growth and differentiation of human hematopoietic cells. J. Biol. Chem. 267 : 18 100 - 18 109.
237. Shinohara K., Tomioka M., Nakano H., Tone S., Ito H., Kawashima S. 1996. Apoptosis induction resulting from proteasome inhibition. Biochem. J. 317 : 385-388.
238. Sikder D., Johnston S. A., Kodadek T. 2006. Widespread, but non-identical, association of proteasomal 19 and 20 S proteins with yeast chromatin. J. Biol. Chem. 281 : 27 346 - 27 355.
239. Smalle J., Vierstra D. 2004. The ubiquitin 26S proteasome proteolytic pathway. Annu. Rev. Plant Biol. 55 : 555-590.
240. Sohn D., Totzke G., Essmann F., Schulze-Osthoff K., Lev- kau B., Janicke R. U. 2006a. The proteasome is required for rapid initiation of death receptor-induced apoptosis. Mol. Cell. Biol. 26 : 1967-1978.
241. Sohn D., Totzke G., Schulze-OsthoffK., Janicke R. U. 2006b. Friend or foe? The proteasome in combined cancer therapy. Cell Cycle. 5 : 841-845.
242. Soza A., Knuehl C., Groettrup M., Henklein P., Tanaka K., Kloetzel P.-M. 1997. Expression and subcellular localization of mouse 20S proteasome activator complex PA28. FEBS Lett. 413 : 27-34.
243. Sumegi M., Hunyadi-Gulyas E., Medzihradszky K. F., Udvardy A. 2003. 26S proteasome subunits are O-linked N-acetylglucosamine-modified in Drosophila melanogaster. Biochem. Biophys. Res. Commun. 312 : 1284-1289.
244. Sun L., Johnston S. A., Kodadek T. 2002. Physical association of the APIS complex and general transcription factors. Biochem. Biophys. Res. Commun. 296 : 991-999.
245. Sun Z. W., Allis C. D. 2002. Ubiquitination of histone H2B regulates H3 methylation and gene silencing in yeast. Nature. 418 : 104-108.
246. Suzuki Y., Nakabayashi Y., Takahashi R. 2001. Ubiquitin-protein ligase activity of X-linked inhibitor of apoptosis protein promotes proteasomal degradation of caspase-3 and enhances its antia-poptotic effect in Fas-induced cell death. Proc. Nat. Acad. Sci. USA. 98 : 8662-8667.
247. Sweder K., Madura K. 2002. Regulation of repair by the 26S proteasome. J. Biomed. Biotechnol. 2 : 94-105.
248. Tabata M., Tabata R., Grabowski D. R., Bukowski R. M. Ganapathi M. K., Ganapathi R. 2001. Roles of NF-kappaB and 26 S proteasome in apoptotic cell death induced by topoisomerase I and II poisons in human nonsmall cell lung carcinoma. J. Biol. Chem. 276 : 8029-8036.
249. Tamura T., Nagy I., Lupas A., Lottspeich F., Cejka Z., Schoofs G., Tanaka K., De Mot R., Baumeister W. 1995. The first characterization of a eubacterial proteasome: the 20S complex of Rhodococcus. Curr. Biol. 5 : 766-774.
250. Tanahashi N., Murakami Y., Minami Y., Shimbara N., Hen- dil K. B., Tanaka K. 2000. Induction by interferon- and contribution to ATP-dependent proteolysis. J. Biol. Chem. 275 : 14 336 - 14 345.
251. Tanaka K., Kawakami T., Tateishi K., Yashiroda H., Chiba T. 2001. Control of IkappaBalpha proteolysis by the ubiquitin-protea-some pathway. Biochimie. 83 : 351-356.
252. Tani E., Kitagawa H., Ikemoto H., Matsumoto T. 2001. Proteasome inhibitors induce Fas-mediated apoptosis by c-Myc accumulation and subsequent induction of FasL message in human glioma cells. FEBS Lett. 504 : 53-58.
253. Tanimoto Y., Kizaki H. 2002. Proteasome inhibitors block ras/ERK signaling pathway resulting in the downregulation of Fas ligand expression during activation-induced cell death in T cells. J. Biochem. 13 1: 319-326.
254. Tanimoto Y., Onishi Y., Hashimoto S., Kizaki H. 1997. Peptidyl aldehyde inhibitors of proteasome induce apoptosis rapidly in mouse lymphoma RVC cells. J. Biochem. 121 : 542-549.
255. Tansey W. P. 2001. Transcriptional activation: risky business. Genes Develop. 15 : 1045-1050.
256. 2+-free calmodulin and calmodulin damaged by in vitro aging are selectively degraded by 26 S proteasomes without ubiquitination. J. Biol. Chem. 275 : 20 295 - 20 301.
257. Tewari M. K., Sinnathamby G., Rajagopal D., Eisenlohr L. C. 2005. A cytosolic pathway for MHC class II-restricted antigen processing that is proteasome and TAP dependent. Nat. Immunol. 6 : 287-294.
258. To W. Y., Wang C. C. 1997. Identification and characterization of an activated 20S proteasome in Trypanosoma brucei. FEBS Lett. 404 : 253-262.
259. Tokumoto M., Horiguchi R., Nagahama Y., Ishikawa K., Tokumoto T. 2000. Two proteins, a goldfish 20S proteasome subunit and the protein interacting with 26S proteasome, change in the meiotic cell cycle. Eur. J. Biochem. 267 : 97-103.
260. Tokumoto M., Horiguchi R., Nagahama Y., Tokumoto T. 1999. Identification of the Xenopus 20S proteasome alpha4 subunit which is modified in the meiotic cell cycle. Gene. 239 : 301-308.
261. Tokunaga F., Aruga R., Iwanaga S., Tanaka K., Ichihara A., Takao T., Shimonishi Y. 1990. The NH2-terminal residues of rat liver proteasome (multicatalytic proteinase complex) subunits, C2, C3 and C8, are Nα-acetylated. FEBS Lett. 263 : 373-375.
262. Touitou R., Richardson J., Bose S., Nakanishi M., Rivett J., Al- lday M. J. 2001. A degradation signal located in the C-terminus of p21WAF1/CIP1 is a binding site for the C8 alpha-subunit of the 20S proteasome. EMBO J. 20 : 2367-2375.
263. Traenckner E. B., Wilk S. Baeuerle P. A. 1994. A proteasome inhibitor prevents activation of NFkB and stabilizes a newly phosphorylated form of I kappa B-alpha that is still bound to NFκB. EMBO J. 13 : 5433-5441.
264. Tsimokha A. S., Mittenberg A. G., Kulichkova V. A., Kozhu- kharova I. V., Gause L. N., Konstantinova I. M. 2007. Changes in composition and activities of 26S proteasomes under the action of doxorubicin - apoptosis inductor of erythroleukemic K562 cells. Cell Biol. Int. 31 : 338-348.
265. Umeda M., Manabe Y., Uchimiya H. 1997. Phosphorylation of the C2 subunit of the proteasome in rice (Oryza sativa L.). FEBS Lett. 403 : 303-307.
266. Ustrell V., Hoffman L., Pratt G., Rechsteiner M. 2002. PA200, a nuclear proteasome activator involved in DNA repair. EMBO J. 21 : 3516-3525.
267. Ustrell V., Pratt G., Gorbea C., Rechsteiner M. 2005. Purification and assay of proteasome activator PA200. Methods Enzymol. 398 : 321-329.
268. Vink J., Cloos J., Kaspers G. J. 2006. Proteasome inhibition as novel treatment strategy in leukaemia. Br. J. Haematol. 134 : 253-262.
269. Viteri G., Carrard G., Birlouez-Aragon I., Silva E., Friguet B. 2004. Age-dependent protein modifications and declining proteasome activity in the human lens. Arch. Biochem. Biophys. 427 : 197-203.
270. Volker C., Lupas A. N. 2002. Molecular evolution of proteasomes. Curr. Top. Microbiol. Immunol. 268 : 1-22.
271. Von Mikecz A. 2006. The nuclear ubiquitin-proteasome system. J. Cell Sci. 119 : 1977-1984.
272. Wakata Y., Tokumoto M., Horiguchi R., Ishikawa K., Nagaha- ma Y., Tokumoto T. 2004. Identification of alpha-type subunits of the Xenopus 20S proteasome and analysis of their changes during the meiotic cell cycle. BMC Biochem. 5 : 18.
273. Wallace A. D., Cidlowski J. A. 2001. Proteasomemediated glucocorticoid receptor degradation restricts transcriptional signaling by glucocorticoids. J. Biol. Chem. 276 : 42 714 - 42 721.
274. Walz J., Erdmann A., Kania M., Typke D., Koster A. J., Baumeister W. 1998. 26S proteasome structure revealed by three-dimensional electron microscopy. J. Struct. Biol. 121 : 19-29.
275. Wang C. Y., Mayo M.W., Baldwin A. S. Jr. 1996. TNF and cancer therapy-induced apoptosis: potentiation by inhibition of NFkB. Science. 274 : 787-789.
276. Wang H. R., Kania M., Baumeister W., Nederlof P. M. 1997. Import of human and Thermoplasma 20S proteasomes into nuclei of HeLa cells requires functional NLS sequences. Eur. J. Cell Biol. 73 : 105-113.
277. Wang J., Maldonado M. A. 2006. The ubiquitin-proteasome system and its role in inflammatory and autoimmune diseases. Cell Mol. Immunol. 3 : 255-261.
278. Wang X. W. 1999. Role of p53 and apoptosis in carcinogenesis. Anticancer Res. 19 : 4759-4771.
279. Wang X., Chen C., Baker P. R., Chen P., Kaiser P., Huang L. 2007. Mass spectrometric characterization of the affinity-purified human 26S proteasome complex. Biochemistry. 46 : 3553-3565.
280. Wehren A., Meyer H. E., Sobek A., Kloetzel P. M., Dahlmann B. 1996. Phosphoamino acids in proteasome subunits. Biol. Chem. 377 : 497-503.
281. Wells L., Vosseller K., Cole R. N., Cronshaw J. M., Matunis M. J., Hart G. W. 2002. Mapping sites of O-GlcNAc modification using affinity tags for serine and threonine post-translational modifications. Mol. Cell Proteomics. 1 : 791-804.
282. Witt E., Zantopf D., Schmidt M., Kraft R., Kloetzel P. M., Kruger E. 2000. Characterization of the newly identified human Ump1 homologue POMP and analysis of LMP7 (beta 5i) incorporation into 20S proteasomes. J. Mol. Biol. 301 : 1-9.
283. Wojcik C. 1999. Inhibition of the proteasome as a therapeutic approach. Drug Discov. Today. 4 : 188-192.
284. Wojcik C. 2002. Regulation of apoptosis by the ubiquitin and proteasome pathway. J. Cell Mol. Med. 6 : 25-48.
285. Wojcik C., Bury M., Stoklosa T., Giermasz A., Feleszko W., Mlynarczuk I., Pleban E., Basak G., Omura S., Jakobisiak M. 2000. Lovastatin and simvastatin are modulators of the proteasome. Int. J. Biochem. Cell Biol. 32 : 957-965.
286. Wojcik C., DeMartino G. N. 2003. Intracellular localization of proteasomes. Int. J. Biochem. Cell Biol. 35 : 579-589.
287. 2-phase and metaphase in HeLa cells. Eur. J. Cell Biol. 70 : 172-178.
288. Wolf D. H. 2004. From lysosome to proteasome: the power of yeast in the dissection of proteinase function in cellular regulation and waste disposal. Cell Mol. Life Sci. 61 : 1-14.
289. Wolf D. H., Hilt W. 2004. The proteasome: a proteolytic nano-machine of cell regulation and waste disposal. Biochim. biophys. acta. 1695 : 19-31.
290. Yang W., Monroe J., Zhang Y., George D., Bremer E., Li H. 2006. Proteasome inhibition induces both pro- and anti-cell death pathways in prostate cancer cells. Cancer Lett. 243 : 217-227.
291. Yang Y., Fang S., Jensen J.P., Weissman A. M., Ashwell J. D. 2000. Ubiquitin protein ligase activity of IAPs and their degradation in proteasomes in response to apoptotic stimuli. Science. 288 : 874-877.
292. Yang Y., Yu X. 2003. Regulation of apoptosis: the ubiquitous way. FASEB J. 17 : 790-799.
293. Yao Y., Huang L., Krutchinsky A., Wong M. L., Standing K. G., Burlingame A. L., Wang C. C. 1999. Structural and functional characterizations of the proteasome-activating protein PA26 from Trypanosoma brucei. J. Biol. Chem. 274 : 33 921 - 33 930.
294. Zachara N. E., Hart G. W. 2004. O-GlcNAc modification: a nutritional sensor that modulates proteasome function. Trends Cell Biol. 14 : 218-221.
295. Zhang F., Hu Y., Huang P., Toleman C. A., Paterson A. J., Kudlow J. E. 2007. Proteasome function is regulated by cyclic AMP-dependent protein kinase through phosphorylation of Rpt6. J. Biol. Chem. 282 : 22 460 - 22 471.
296. Zhang F., Su K., Yang X., Bowe D. B., Paterson A. J., Kudlow J. E. 2003. O-GlcNAc modification is an endogenous inhibitor of the proteasome. Cell. 115 : 715-725.
297. Zhang H., Sun L., Liang J., Yu W., Zhang Y., Wang Y., Chen Y., Li R., Sun X., Shang Y. 2006. The catalytic subunit of the proteasome is engaged in the entire process of estrogen receptor-regulated transcription. EMBO J. 25 : 4223-4233.
298. Zhou P. 2005. Targeted protein degradation. Curr. Opin. Chem. Biol. 9 : 51-55.